View Older Stories View More Recent Stories

Aug 5, 2019 07:00AM Syndax to Participate in the BTIG Biotechnology Conference
Jul 31, 2019 07:00AM Syndax to Announce Second Quarter 2019 Financial Results and Host Conference Call and Webcast on August 7, 2019
Jul 10, 2019 07:03AM Syndax Pharmaceuticals (SNDX) Reports FDA Clearance of IND Application for Targeted Menin Inhibitor SNDX-5613 for Relapsed/Refractory Acute Leukemias
Jul 10, 2019 07:00AM Syndax Pharmaceuticals Announces FDA Clearance of IND Application for Targeted Menin Inhibitor SNDX-5613 for Relapsed/Refractory Acute Leukemias
Jun 13, 2019 07:00AM Syndax to Present at the JMP Securities Life Sciences Conference
May 14, 2019 07:00AM Syndax to Present at the UBS Global Healthcare Conference
May 6, 2019 04:05PM Syndax Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Clinical and Business Update
Apr 29, 2019 07:00AM Syndax to Announce First Quarter 2019 Financial Results and Host Conference Call and Webcast on May 6, 2019
Apr 1, 2019 10:36AM Syndax Pharmaceuticals (SNDX) Presents Updated Phase 2 Data from ENCORE 601 Trial of Entinostat in Combination with KEYTRUDA at AACR
Apr 1, 2019 10:33AM Syndax Pharmaceuticals Presents Updated Phase 2 Data from ENCORE 601 Trial of Entinostat in Combination with KEYTRUDA® (pembrolizumab) at the American Association for Cancer Research 2019 Annual Meet
Mar 27, 2019 07:02AM Syndax Pharmaceuticals (SNDX) Prices 4.366M Share Offering at $6/Sh
Mar 27, 2019 07:00AM Syndax Announces $26.2 Million Offering of Common Stock and Warrants
Mar 7, 2019 04:05PM Syndax Pharmaceuticals Reports Fourth Quarter 2018 Financial Results and Provides Clinical and Business Update
Mar 6, 2019 07:00AM Syndax to Present at the Cowen 39th Annual Health Care Conference
Feb 28, 2019 07:00AM Syndax to Announce Fourth Quarter and Year-end 2018 Financial Results and Host Conference Call and Webcast on March 7, 2019
Feb 27, 2019 04:47PM Syndax Announces Clinical Data from its Entinostat Immuno-oncology Program Selected for Two Oral Presentations at the American Association for Cancer Research Annual Meeting 2019
Jan 7, 2019 07:27AM Syndax Pharmaceuticals (SNDX) Announces 2019 Clinical and Corporate Outlook; Provides 2019 Financial Guidance
Jan 7, 2019 07:00AM Syndax Highlights 2019 Clinical and Corporate Outlook
Dec 3, 2018 10:03AM Syndax Pharmaceuticals (SNDX) Announces Presentation of Preclinical Data from Menin-MLL Program at ASH
Dec 3, 2018 10:00AM Syndax Pharmaceuticals Announces Presentation of Preclinical Data from Menin-MLL Program at the 60th American Society of Hematology Annual Meeting
Nov 5, 2018 04:05PM Syndax Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Clinical and Business Update
Nov 1, 2018 04:09PM Syndax Pharmaceuticals Announces Presentations at the 60th American Society of Hematology Annual Meeting
Oct 29, 2018 07:00AM Syndax to Announce Third Quarter 2018 Financial Results and Host Conference Call and Webcast on November 5, 2018
Oct 25, 2018 04:59PM Syndax Pharmaceuticals (SNDX) Says Phase 3 Breast Cancer Trial E2112 Shows PFS not Statistically Significant
Oct 25, 2018 04:05PM Syndax to Host Conference Call to Provide Update on the Phase 3 Breast Cancer Trial (E2112) and to Announce its Registration Trial of Entinostat with Keytruda in PD-(L)1 Refractory Non-Small Cell Lung
Sep 26, 2018 07:00AM Syndax to Present at the 2018 Cantor Global Healthcare Conference
Sep 25, 2018 04:12PM Syndax Pharmaceuticals (SNDX) Appoints Jennifer Jarrett and William Meury to Board Succeeding Luke Evnin Ph.D. and Henry Chen
Sep 25, 2018 04:05PM Syndax Announces Changes to its Board of Directors
Sep 24, 2018 04:07PM Syndax Pharmaceuticals (SNDX) Reports Updated Results from Phase 2 ENCORE 601 Trial of Entinostat in Combination with KEYTRUDA (pembrolizumab) in NSCLC
Sep 24, 2018 04:05PM Syndax Announces Updated Results from Phase 2 ENCORE 601 Trial of Entinostat in Combination with KEYTRUDA® (pembrolizumab) in Non-Small Cell Lung Cancer
Sep 5, 2018 05:00PM Syndax to Present at the International Association for the Study of Lung Cancer 19th World Conference on Lung Cancer
Aug 28, 2018 07:00AM Syndax Announces Participation at Three Upcoming Investor Conferences
Aug 7, 2018 04:05PM Syndax Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Clinical and Business Update
Jul 31, 2018 07:00AM Syndax to Announce Second Quarter 2018 Financial Results and Host Conference Call and Webcast on August 7, 2018
Jul 12, 2018 09:15AM Pre-Open Movers 07/12: (ZGNX) (GLMD) (CA) Higher; (ZN) (ACRX) (AVGO) Lower (more...)
May 30, 2018 04:05PM Syndax and Nektar Therapeutics Announce Immuno-Oncology Clinical Trial Collaboration
May 30, 2018 07:00AM Syndax Pharmaceuticals Announces Participation at Two Upcoming Investor Conferences
May 17, 2018 07:07AM Syndax (SNDX) Announces Updated Results from Phase 2 ENCORE 601 Trial of Entinostat in Combination with KEYTRUDA
May 17, 2018 07:00AM Syndax Announces Updated Results from Phase 2 ENCORE 601 Trial of Entinostat in Combination with KEYTRUDA® (pembrolizumab)
May 8, 2018 04:05PM Syndax Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Clinical and Business Update
May 1, 2018 07:00AM Syndax to Announce First Quarter 2018 Financial Results and Host Conference Call and Webcast on May 8, 2018
Apr 25, 2018 04:05PM Syndax Pharmaceuticals Announces Presentations at the 2018 American Society of Clinical Oncology Annual Meeting
Apr 13, 2018 07:00AM Syndax to Present at the 2018 American Association for Cancer Research Annual Meeting
Mar 5, 2018 04:05PM Syndax Pharmaceuticals Reports Fourth Quarter 2017 Financial Results and Provides Clinical and Business Update
Mar 5, 2018 07:00AM Syndax Pharmaceuticals Announces Participation at Two Upcoming Investor Conferences
Feb 26, 2018 07:00AM Syndax to Announce Fourth Quarter and Year-end 2017 Financial Results and Host Conference Call and Webcast on March 5, 2018
Feb 22, 2018 07:00AM Syndax Announces Presentations at the 2018 American Association for Cancer Research Annual Meeting
Feb 1, 2018 07:15AM Syndax Pharmaceuticals (SNDX) Reports Immuno-Oncology Clinical Trial Collaboration with AstraZeneca
Feb 1, 2018 07:00AM Syndax Announces Immuno-Oncology Clinical Trial Collaboration with AstraZeneca
Dec 20, 2017 08:00AM Loncar Cancer Immunotherapy Index Conducts Semi-Annual Rebalance
View More Recent Stories View Older Stories